Cochlear Limited
Research Cochlear Limited (OC5) on Bullrun: market cap EUR 5.36B, P/E 59.4, dividend yield 3.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOC5
- ExchangeF
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 5.36B
- P/E59.4
- Dividend yield3.1%
- Financial periodFY2025
- RevenueAUD 2.34B
- Revenue growth4.8%
- Net incomeAUD 388.90M
- Free cash flowAUD 135.00M
- Gross margin73.7%
Valuation Snapshot
latest market cap is EUR 5.36B; P/E is 59.4; dividend yield is 3.1%.
Peer valuation comparison
Latest P/E is 59.38x versus a Healthcare sector median of 24.46x (142.8% above).
Latest dividend yield is 3.11% versus a Healthcare sector median of 2.11% (47.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 2.34B | AUD 388.90M | AUD 135.00M | 73.7% | 5.94 | AUD 275.70M | AUD 235.70M | AUD 1.95B |
| FY2024 | AUD 2.24B | AUD 356.80M | AUD 299.00M | 74.9% | 5.43 | AUD 513.60M | AUD 243.70M | AUD 1.84B |
| FY2023 | AUD 1.94B | AUD 300.60M | AUD 266.50M | 74.8% | 4.56 | AUD 555.50M | AUD 201.80M | AUD 1.75B |
| FY2022 | AUD 1.65B | AUD 289.10M | AUD 299.30M | 75.1% | 4.4 | AUD 629.30M | AUD 253.90M | AUD 1.69B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 5.36B | 59.4 | 1.9% | 1.59 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.59 EUR, yield 3.1%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.61 AUD |
| FY2024 | 2.49 AUD |
| FY2023 | 2 AUD |
| FY2022 | 1.82 AUD |
| FY2021 | 1.55 AUD |
About Cochlear Limited
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cochlear Limited's market cap?
Cochlear Limited's market capitalization is EUR 5.36B.
What is Cochlear Limited's P/E ratio?
Cochlear Limited's price-to-earnings (P/E) ratio is 59.4.
Does Cochlear Limited pay a dividend?
Cochlear Limited has a dividend yield of 3.1%.
What does Cochlear Limited do?
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link.